<!DOCTYPE HTML>
<!--
	Massively by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>Synaptic Nomad</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
		<noscript><link rel="stylesheet" href="assets/css/noscript.css" /></noscript>
			<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="msapplication-TileImage" content="images/favicon-1.png">
	<meta name="msapplication-TileColor" content="#caddee">
	<link rel="apple-touch-icon" type="image/png" href="images/apple-touch-icon-1.png">
	<link rel="apple-touch-icon" type="image/png" sizes="32x32" href="images/favicon-32x32-1-apple.png">
	<link rel="apple-touch-icon" type="image/png" sizes="16x16" href="images/favicon-16x16-1-apple.png">
	<link rel="apple-touch-icon" type="image/png" sizes="192x192" href="images/apple-touch-192x192-1.png">
	<link rel="apple-touch-icon" type="image/png" sizes="512x512" href="images/apple-touch-512x512-1.png">
	<link rel="icon" type="image/png" sizes="32x32" href="images/favicon-32x32-1.png">
	<link rel="icon" type="image/png" sizes="16x16" href="images/favicon-16x16-1.png"> 
	<meta content="yes" name="apple-mobile-web-app-capable">
	<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
	<link rel="icon" type="image/png" href="images/favicon-96x96.png" sizes="96x96" >
	<link rel="icon" type="image/svg+xml" href="images/favicon.svg" >
	<link rel="mask-icon" href="images/favicon.svg" color="#caddee">
	<link rel="shortcut icon" href="images/favicon.ico" >
	<meta name="apple-mobile-web-app-title" content="Primer" >
	<link rel="manifest" href="images/site.webmanifest">
	<link rel="apple-touch-icon" sizes="57x57" href="images/apple-icon-57x57.png">
	<link rel="apple-touch-icon" sizes="60x60" href="images/apple-icon-60x60.png">
	<link rel="apple-touch-icon" sizes="72x72" href="images/apple-icon-72x72.png">
	<link rel="apple-touch-icon" sizes="76x76" href="images/apple-icon-76x76.png">
	<link rel="apple-touch-icon" sizes="114x114" href="images/apple-icon-114x114.png">
	<link rel="apple-touch-icon" sizes="120x120" href="images/apple-icon-120x120.png">
	<link rel="apple-touch-icon" sizes="144x144" href="images/apple-icon-144x144.png">
	<link rel="apple-touch-icon" sizes="152x152" href="images/apple-icon-152x152.png">
	<link rel="apple-touch-icon" sizes="180x180" href="images/apple-icon-180x180.png">
	<link rel="icon" type="image/png" sizes="192x192"  href="images/android-icon-192x192.png">
	<link rel="icon" type="image/png" sizes="32x32" href="images/favicon-32x32.png">
	<link rel="icon" type="image/png" sizes="96x96" href="images/favicon-96x96.png">
	<link rel="icon" type="image/png" sizes="16x16" href="images/favicon-16x16.png">
	<link rel="manifest" href="images/manifest.json">
	<meta name="msapplication-TileImage" content="images/ms-icon-144x144.png"> 
		
	</head>
	<body class="is-preload">

		<!-- Wrapper -->
			<div id="wrapper" class="fade-in">

				<!-- Intro -->
					<div id="intro">
						<h1>Synaptic<br />
						Nomad</h1>
						<p>Traveling through Asia to communicate<br />
						the <a href="http://synapticpriming.com/">synaptic priming framework.</a></p>
						<ul class="actions">
							<li><a href="#header" class="button icon solid solo fa-arrow-down scrolly">Continue</a></li>
						</ul>
					</div>

				<!-- Header -->
					<header id="header">
						<a href="index.html" class="logo">Synaptic priming</a>
					</header>

				<!-- Nav -->
					<nav id="nav">
						<ul class="links">
							<li class="active"><a href="index.html">Synaptic Nomad</a></li>
						</ul>
						<ul class="icons">
							<li><a href="mailto: synaptic.priming@gmail.com" class="icon fa-envelope"><span class="label">Email</span></a></li>
							<li><a href="https://scholar.google.com/citations?user=azKfXbsAAAAJ&hl=en&oi=ao" class="icon brands fa-google"><span class="label">Google</span></a></li>
							<li><a href="https://www.instagram.com/synaptic.nomad?igsh=aHl5ZjV6N2c4MGxt" class="icon brands fa-instagram"><span class="label">Instagram</span></a></li>
							<li><a href="https://www.linkedin.com/in/kyleabrown/" class="icon brands fa-linkedin"><span class="label">LinkedIn</span></a></li>
							<li><a href="https://x.com/SynapticPriming" class="icon brands fa-twitter"><span class="label">Twitter</span></a></li>
							<li><a href="https://wa.me/16785427932" class="icon brands fa-whatsapp"><span class="label">Whatsapp</span></a></li>
					  		</ul>	
					</nav>

				<!-- Main -->
					<div id="main">

						<!-- Featured Post -->
							<article class="post featured">
								<header class="major">
									<span class="date">May 29, 2025</span>
									<h2><a href="https://doi.org/10.1038/s41586-025-08813-6">Making synapses<br />
									with psychedelics</a></h2>
									<p>Dr. Brown hosts Dr. Alex Kwan, Associate Professor of Biomedical Engineering at Cornell University, <br />
									for a UM-MIND Seminar on the therapeutic, structural plasticity evoked by psychedelics.<br />
									</p>
								</header>
								<a href="https://doi.org/10.1038/s41586-025-08813-6" class="image main"><img src="images/KB kwan.jpg" alt="" /></a>
								<ul class="actions special">
									<li><a href="https://doi.org/10.1038/s41586-025-08813-6" class="button large">Learn More</a></li>
								</ul>
							</article>

						<!-- Posts -->
							<section class="posts">
								<article>
									<header>
										<span class="date">March 17, 2025</span>
										<h2><a href="https://doi.org/10.1038/s41386-025-02085-4">Ketamine metabolite <br />
										primes plasticity</a></h2>
									</header>
									<a href="https://doi.org/10.1038/s41386-025-02085-4" class="image fit"><img src="images/kb npp.png" alt="" /></a>
									<p>In this article, we show that rapid synaptic potentiation evoked by ketamine metabolite
									(2R,6R)-hydroxynorketamine persistently increases the ability
									for hippocampal synaptic plasticity, an effect previously attributed only to ketamine.</p>
									<ul class="actions special">
										<li><a href="https://doi.org/10.1038/s41386-025-02085-4" class="button">Full Story</a></li>
									</ul>
								</article>
								<article>
									<header>
										<span class="date">December 16, 2024</span>
										<h2><a href="https://doi.org/10.1152/jn.00353.2024">Dopamine and opioid<br />
										synaptic plasticity</a></h2>
									</header>
									<a href="https://doi.org/10.1152/jn.00353.2024" class="image fit"><img src="images/kb jnp.png" alt="" /></a>
									<p>Postsynaptic dopamine D3 receptors in the hippocampus are selectively targeted by inputs from Âµ-opioid receptor-expressing GABAergic terminals,
										suggesting an inhibitory CA1 synapse is uniquely regulated by dopaminergic and opioidergic signaling.</p>
									<ul class="actions special">
										<li><a href="https://doi.org/10.1152/jn.00353.2024" class="button">Full Story</a></li>
									</ul>
								</article>
								<article>
									<header>
										<span class="date">December 5, 2024</span>
										<h2><a href="https://www.youtube.com/watch?v=sok4TNBxjs0">Novel Therapeutics in Depression: <br />
										Ketamine, Esketamine, and Psychedelics</a></h2>
									</header>
									<a href="https://www.youtube.com/watch?v=sok4TNBxjs0" class="image fit"><img src="images/Grand rounds flyer-Sam Wilkinson.png" alt="" /></a>
									<p>Dr. Brown hosts Dr. Samuel Wilkinson, the Associate Director of the Yale Depression Research Program, 
									for a Grand Rounds talk on ketamine and psychedelic use in clinical care for depression.</p>
									<ul class="actions special">
										<li><a href="https://www.youtube.com/watch?v=sok4TNBxjs0" class="button">Full Talk</a></li>
									</ul>
								</article>
								<article>
									<header>
									<span class="date">May 28, 2024</span>
									<h2><a href="https://doi.org/10.1016/s2215-0366(23)00183-9">The future of Ketamine and Esketamine in Depression: <br />
									a translational perspective</a></h2>
									</header>
									<a href="https://doi.org/10.1016/s2215-0366(23)00183-9" class="image fit"><img src="images/ASCP panel.jpeg" alt="" /></a>
									<p>Drs. Gustavo Medeiros (Johns Hopkins), Jennifer Vande Voort (Mayo Clinic), and Dan Iosifescu (NYU School of Medicine) join Dr. Brown 
									on a panel at the American Society of Clinical Psychopharmacology meeting to discuss current and new therapeutic uses of ketamine/esketamine.</p>
									<ul class="actions special">
										<li><a href="https://doi.org/10.1016/s2215-0366(23)00183-9" class="button">Learn More</a></li>
									</ul>
								</article>
								<article>
									<header>
										<span class="date">January 4, 2024</span>
										<h2><a href="https://doi.org/10.1038/s41380-023-02397-1">Targeting synaptic plasticity<br />
										mechanisms in the treatment of depression</a></h2>
									</header>
									<a href="https://doi.org/10.1038/s41380-023-02397-1" class="image fit"><img src="images/kb mol psych.png" alt="" /></a>
									<p>Ketamine persistently changes the ability for synaptic plasticity, suggesting a form of metaplasticity.
									In this review, we describe the mechanisms associated with this metaplasticity, and if metaplasticity is linked to the antidepressant actions of ketamine.</p>
									<ul class="actions special">
										<li><a href="https://doi.org/10.1038/s41380-023-02397-1" class="button">Full Story</a></li>
									</ul>
								</article>
								<article>
								<header>
								<span class="date">October 24, 2023</span>
									<h2><a href="https://doi.org/10.1038/s41380-023-02397-1">Metaplasticity: <br />
									a process that can be harnessed for treating depression?</a></h2>
									</header>
									<a href="https://doi.org/10.1038/s41380-023-02397-1" class="image fit"><img src="images/KB BBS.jpeg" alt="" /></a>
									<p>At the Baltimore Brain Seminar Series hosted at Johns Hopkins University, Dr. Brown discusses whether  
									ketamine and its metabolites exert long-lasting antidepressant actions through hippocampal metaplasticity.</p>
									<ul class="actions special">
										<li><a href="https://doi.org/10.1038/s41380-023-02397-1" class="button">Full Story</a></li>
									</ul>
								</article>
								<article>
									<header>
									<span class="date">July 24, 2023</span>
									<h2><a href="https://doi.org/10.1038/s41386-023-01675-4">Ketamine preservative <br />
									potentiates hippocampal synaptic strength</a></h2>
									</header>
									<a href="https://doi.org/10.1038/s41386-023-01675-4" class="image fit"><img src="images/kb npp bzt.png" alt="" /></a>
									<p>Some studies have shown that ketamine rapidly enhances hippocampal synaptic strength, but others found no effect. In this article,
									we show that a preservative in veterinary ketamine formulations potentiates synaptic strength, suggesting that
									it may be responsible for synaptic actions previously attributed to ketamine.</p>
									<ul class="actions special">
										<li><a href="https://doi.org/10.1038/s41386-023-01675-4" class="button">Full Story</a></li>
									</ul>
								</article>
								<article>
									<header>
									<span class="date">February 8, 2023</span>
									<h2><a href="https://doi.org/10.1523/JNEUROSCI.1316-22.2022">Ketamine requires NMDAR activity <br />
									to exert antidepressant-like effects in mice</a></h2>
									</header>
									<a href="https://doi.org/10.1523/JNEUROSCI.1316-22.2022" class="image fit"><img src="images/zanos kb j neuro.png" alt="" /></a>
									<p>The antidepressant actions of ketamine are commonly attributed to its action as an NMDAR antagonist. In this article,
									we show that sustained antidepressant synaptic and behavioral actions of ketamine actually require NMDAR activity.</p>
									<ul class="actions special">
										<li><a href="https://doi.org/10.1523/JNEUROSCI.1316-22.2022" class="button">Full Story</a></li>
									</ul>
								</article>
							</section>

						<!-- Footer AND BEYOND: ORIGINAL FILE CONTAINS NUMEROUS FEATURES FOR MORE BOXES OF PAPERS/STUFF TO SHOW, ARROWS TO GO TO DIFFERENT SUBPAGES, ETC. -->
							<footer style="display:none"> 
								
							</footer>

					</div>

				<!-- Footer -->
					<footer id="footer">
						<section>
							<form method="post" action="https://formspree.io/f/xjkwdbnb">
								<div class="fields">
									<div class="field">
										<label for="name">Name</label>
										<input type="text" name="name" id="name" />
									</div>
									<div class="field">
										<label for="email">Email</label>
										<input type="text" name="email" id="email" />
									</div>
									<div class="field">
										<label for="message">Message</label>
										<textarea name="message" id="message" rows="3"></textarea>
									</div>
								</div>
								<ul class="actions">
									<li><input type="submit" value="Send Message" /></li>
								</ul>
							</form>
						</section>
						<section class="split contact">
							<section class="alt">
								<h3>Address</h3>
								<p>10 S Pine St.,<br />
								Baltimore, MD, USA</p>
							</section>
							<section>
								<h3>Phone</h3>
								<p><a href="https://wa.me/16785427932"> +1-(678) 542-7932</a></p>
							</section>
							<section>
								<h3>Email</h3>
								<p><a href="mailto: synaptic.priming@gmail.com">synaptic.priming@gmail.com</a></p>
							</section>
							<section>
								<h3>Social</h3>
								<ul class="icons alt">
								<li><a href="mailto: synaptic.priming@gmail.com" class="icon fa-envelope"><span class="label">Email</span></a></li>
								<li><a href="https://scholar.google.com/citations?user=azKfXbsAAAAJ&hl=en&oi=ao" class="icon brands fa-google"><span class="label">Google</span></a></li>
								<li><a href="https://www.instagram.com/synaptic.nomad?igsh=aHl5ZjV6N2c4MGxt" class="icon brands fa-instagram"><span class="label">Instagram</span></a></li>
								<li><a href="https://www.linkedin.com/in/kyleabrown/" class="icon brands fa-linkedin"><span class="label">LinkedIn</span></a></li>
								<li><a href="https://x.com/SynapticPriming" class="icon brands fa-twitter"><span class="label">Twitter</span></a></li>
								<li><a href="https://wa.me/16785427932" class="icon brands fa-whatsapp"><span class="label">Whatsapp</span></a></li>
								</ul>
							</section>
						</section>
					</footer>

				<!-- Copyright -->
					<div id="copyright">
						<ul><li>&copy; Synaptic Nomad</li></ul>
					</div>

			</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/jquery.scrollex.min.js"></script>
			<script src="assets/js/jquery.scrolly.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>
